Sinopharm Group Co. Ltd.
Sinopharm Group Building
No. 385, East Longhua Road Huangpu District
Shanghai 200023
China
86 21 2305 2666
https://www.sinopharmgroup.com.cn
版塊: Healthcare
行業: Medical Distribution
全職員工: 115,959
高階主管
| 名稱 | 頭銜 | 支付 | 行使價 | 出生年份 |
|---|---|---|---|---|
| Mr. Qingming Yu | Executive Chairman of the Board | 896.17k | 無 | 1964 |
| Mr. Yong Liu | President & Executive Director | 866.62k | 無 | 1969 |
| Ms. Xiaojuan Li | Chief Financial Officer | 無 | 無 | 1976 |
| Mr. Yijian Wu | Secretary to the Board, Company Secretary & Authorised Representative | 無 | 無 | 1970 |
描述
Sinopharm Group Co. Ltd., together with its subsidiaries, engages in the wholesale and retail of pharmaceutical and medical devices and healthcare products in the People's Republic of China. The company operates through four segments: Pharmaceutical Distribution, Medical Devices, Retail Pharmacy, and Other Business. The Pharmaceutical Distribution segment distributes pharmaceutical products to hospitals, other distributors, retail pharmacy stores, and clinics. This segment also offers distribution, logistics, and other value-added services for domestic and international pharmaceutical and healthcare products manufacturers, and other suppliers. The Medical Devices segment distributes medical devices. The Retail Pharmacy segment operates and franchises a network of retail drug stores. The Other Business segment engages in the production and sale of pharmaceutical products, chemical reagents, and laboratory supplies. The company also rents and manages properties; distributes medical instruments, Chinese herbal medicines, antibiotics, and biological products; and offers information technology, investment, goods and technology import and export, business consulting, health consultation, medical consulting, market information consulting and investigation, and convention and exhibition services. In addition, it manages medical project investment, consulting, and technology training activities. The company was founded in 2003 and is headquartered in Shanghai, the People's Republic of China. Sinopharm Group Co. Ltd. is a subsidiary of Sinopharm Industrial Investment Co., Ltd.
公司管治
截至 2024年5月1日 止，Sinopharm Group Co. Ltd. 的 ISS 管治質素評分為 7。 Pillar 分數正在審核中：6；董事會：9；股東權利：9；現金賠償：2。
